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Background

 Canada and the U.S had the
highest level of opioid
consumption per capita
worldwide in 2015
 Nurse Practitioners (NPs) are
health care practitioners who
provide vital care for patients
across the lifespan
 NPs are authorized to prescribe
opioids in both Canada and the
U.S

Purpose

Aim: To examine the differences in
 NP opioid-related educational requirements
 NP opioid prescribing patterns
between the U.S. and Canada.

Methods
 A narrative review was used to synthesize
findings from literature obtained through
computerized databases, authoritative
texts, and hand searches
 Databases included CINAHL, PubMed, and
MEDLINE
 Hand searches identified sources not indexed
in major databases

 Relevant articles from current literature
(within the last 5 years) were included

 As of 2010, NPs in Canada and the U.S.
must hold a master's degree

Discussion:
Educational
Requirements

 American NPs must obtain a Drug
Enforcement Administration (DEA) license
to prescribe opioids
 The Canadian government authorized NPs
to prescribe opioids in 2012, with varying
provincial licensure requirements
 Canadian NPs have expressed less
confidence and education related to opioid
tapering for patients on high doses of opioids
(Pittman, 2021)

Discussion:
Opioid
Prescribing
Guidelines

 New American national guidelines for
prescribing opioids for chronic pain were
released by the Centers for Disease Control
(CDC) and Prevention in 2016
 An update is currently being drafted and will
be released later this year

 McMaster University in Canada quickly
followed and published ‘The 2017
Canadian Guideline for Opioids for Chronic
Non-Cancer Pain.’
 Guidelines in both countries are not
mandatory

Overview of CDC Guidelines for Prescribing Opioids for
Chronic Pain
 Opioids are not first-line or routine therapy for chronic pain
 Establish and measure goals for pain and function
 Discuss benefits and risks and availability of nonopioid therapies with
patient
 Use immediate-release opioids when starting
 Start low and go slow (avoid ≥50 MME/day, limit of 90 MME/day
 When opioids are needed for pain, prescribe no more than needed
 Do not prescribe ER/LA opioids for acute pain
 Follow-up and re-evaluate risk of harm; reduce dose or taper and
discontinue as needed
 Evaluate risk factors for opioid-related harms
 Check PDMP for high dosages and prescriptions from other providers
 Avoid concurrent benzodiazepine
 Use urine drug testing to identify prescribed substances and
undisclosed use and opioid prescribing
 Arrange treatment for opioid use disorder if needed

Recommendations of 2017 Canadian
Guideline for Opioids for Chronic Non-Cancer
Pain.’
 Optimization of nonopioid pharmacotherapy and nonpharmacologic therapy, rather
than a trial of opioids
 Strong recommendation against initiation of opioids for patients with active substance use
disorder
 Initiate opioids in low-risk patients (no current or past substance use disorder, no active
psychiatric disorders) if pain persists
 Restrict initial dose to less than 50 MME daily (maximum upper limit 90 MME/day)
 Taper/ potentially discontinue opioids for patients currently using 90 MME or more daily

 Rotate opioids if current prescription is ineffective
 Taper using multidisciplinary approach if difficulties present

Discussion: Setting-Specific Prescribing Guidelines

 24 American states have
implemented emergency
department (ED) specific opioid
prescribing guidelines
 Canada lacks such
guidelines

Source: CTV News Windsor

Discussion: Monitoring of NP Prescribing

 NP opioid prescribing in the U.S. is
monitored though the DEA drug
monitoring program (PDMP)
 NPs in the U.S. complete a
national survey every 5 years
regarding all prescribing
practices.
 Canada does not have a
monitoring program or
national surveys

Source: OpioidHelp

Implications for Future Research

 Canadian NP opioid prescribing is under-researched
 Further research is needed to provide a more adequate comparison with
American data

 Research regarding ED opioid-specific guidelines could provide valuable
information to guide prescribers in this rapidly changing, high-stress
environment
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